Both in Biotechnology
Vor Biopharma vs Inhibrx Biosciences
Over the past year VOR returned −2.1% and INBX returned +5.8%; their daily moves had a correlation of 0.14.
VOR −2.1% INBX +5.8%Growth of $1, one year, split-adjusted
| Metric | VOR | INBX |
|---|---|---|
| Price | $20.12 | $86.76 |
| Market cap | $1.24B | $1.28B |
| Today | +1.31% | +7.01% |
| 1 month | +9.9% | −7.1% |
| 6 months | +26.5% | −38.8% |
| Year to date | +53.8% | +9.8% |
| 1 year | −10.2% | +6.5% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 0.9× | — |
| Price / sales | — | — |
| Net cash | $481.6M | -$42.9M |
| Dividend yield | — | — |
| Volatility (60d) | 59.2% | 88.8% |
| Short % of float | 17.6% | 35.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).